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ABSTRACT
Intravascular large B-cell lymphoma (IVLBCL) is a very rare extra nodal lymphoma that tends to proliferate within small blood 
vessels, particularly capillaries and postcapillary venules while sparing the organ parenchyma. The cause of its affinity for the 
vascular bed remains unknown. Because of its rarity and unremarkable clinical presentation, a timely diagnosis of IVLBCL 
is very challenging. Here, we describe a case of IVLBCL presenting as pancreatic mass that was ultimately diagnosed at 
autopsy. A 71-year-old Caucasian female presented with a 3-month history of fatigue, abdominal pain, and weight loss. 
She was referred to the emergency room with a new diagnosis of portal vein thrombosis and lactic acidosis. During her 
hospital course she was found to have a 1.9 × 1.8 cm lesion in the pancreatic tail on imaging; The cytologic specimen on 
the mass showed a high-grade lymphoma. A bone marrow biopsy showed no involvement. The patient’s condition rapidly 
deteriorated and she, later, died due to multi-organ failure. An autopsy revealed diffuse intravascular invasion in multiple 
organs by the lymphoma cells. Based on our literature review—and to the best of our knowledge—there are virtually no 
reports describing the presentation of this lymphoma with a discernible tissue mass and associated multi-organ failure. 
The immunophenotypic studies performed revealed de novo CD5+ intravascular large B-cell lymphoma, which is known 
to be aggressive with very poor prognosis. Although it is a very rare lymphoma, it should be considered as a potential 
cause of multi-organ failure when no other cause has been identified. A prompt tissue diagnosis, appropriate high-dose 
chemotherapy and stem cell transplantation remain the only viable alternative to achieve some kind of remission. 
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CASE REPORT
A 71-year-old Caucasian female had a past 
medical history of arthritis, central serous retinopathy, 
remote deep vein thrombosis (not on anticoagulation), 
hyperlipidemia and osteoporosis. She presented with 
a 3-month history of fatigue, abdominal pain and 
loss of appetite. She was referred to the emergency 
room after an outpatient work-up for gradual 
progression of fatigue and anemia. She had a 
hemoglobin of 10.7 g/dL (reference value [RV]: 
13.7-17.5 g/dL), mild thrombocytopenia and abnormal 
liver function tests. During her hospital admission, 
she was afebrile with the following vital signs: pulse 
110 beats/minute, blood pressure 115/80 mmHg, and 
O2 saturation of 95% on room air. Her notable lab 
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values were Na+ 128 mmol/L (RV: 134-146 mmol/L), 
AST 110 U/L (RV: 15-56 U/L), ALT 73 U/L (RV: 11-50 U/L), 
GGTP 94 U/L (RV: 3.0-28.7 IU/L) and albumin 2.6 gm/dL 
(RV: 3.5-5.0 gm/dL). The abdominal computed tomography 
suggested hepatic and portal vein thrombosis, 
with suspicion of hepatitis, pancreatitis, and colitis. 
On magnetic resonance imaging, right hepatic 
vein thrombosis and a 1.9 × 1.8 cm lesion in the 
pancreatic tail was noted; based on the imaging 
studies, a pancreatic carcinoma or a pancreatic 
neuro-endocrine tumor was suspected. A CT-guided 
needle core biopsy on the pancreatic tail mass showed 
multiple foci of large frankly neoplastic cells infiltrating 
normal-appearing pancreatic lobules featuring scant 
cytoplasm, nuclei with regular contour and prominent 
nucleoli; mitotic figures and numerous apoptotic bodies 
were noted. Extensive immunohistochemical work-up 
was unrevealing and proliferation index by Ki-67 was 
high (>95%). Ultimately, the patient was given a 
diagnosis of diffuse large B-cell lymphoma (DLBCL) 
on the concomitant cytology specimen, which was 
the actual diagnostic material. The cell block showed 
highly atypical large cells intermixed with pancreatic 
acini. Those cells were positive for CD20, CD79a, and 
CD45, and focally PAX-5 (Figure 1). Stain for MUM-1 
was non-contributory, and a further sub-classification 
could not be performed. Subsequent bone marrow 
aspirate and biopsy showed no involvement.
Figure 1. Photomicrography of the cell block. A – Highly atypical large cells intermixed with pancreatic acini 
(H&E, 20X). Those cells were positive for CD20 and CD79a in B and C, respectively (10X).
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Her hospita l  course was compl icated by 
Weisella confusa and Enterococcus faecalis bacteremia 
and she was treated with piperacillin-tazobactam 
(ZosynR).  She was noted to have up-trending 
creatinine (0.7 mg/dL to 1.4 mg/dL to 1.7 mg/dL to 
2.1 mg/dL; (RV: 0.6-1.0 mg/dL) and elevated lactate 
dehydrogenase (LDH) (9.1 U/L to 3487 U/L to 8097 U/L 
to 5686 U/L to 4328 U/L to 4636 U/L; (RV:140-280 U/L) 
of unclear etiology reminiscent of tumor lysis albeit 
disproportionate to lymphomatous involvement that at 
the time was thought to be restricted to the pancreas. Her 
diastolic blood pressure was intermittently fluctuating 
from 50 to 90 mmHg and she had up-trending liver 
function tests (AST/ALT: 50/47 U/L to 108/69 U/L 
to 410/155 U/L to 172/101 U/L), all of which were 
refractory to intravenous fluid. Her antibiotic regimen 
was broadened to vancomycin and meropenem and 
later she was transferred to the intensive care unit 
(ICU). With septic shock in mind, she was started 
on metronidazole (FlagylR) and oral vancomycin for 
Clostridium difficile colitis, empirically. Fluids and a 
norepinephrine drip did not improve her lactic acidosis. 
She was intubated due to worsening respiratory status; 
antibiotics were again broadened to vancomycin, 
meropenem, amikacin, micafungin, oral vancomycin, 
and metronidazole. Stress dose steroids were also 
given. She subsequently developed disseminated 
intravascular coagulopathy, pulmonary emboli and 
rapidly evolved into irreversible multi-organ failure 
ultimately resulting in the patient’s demise at day 
13 after admission. There was an informed consent 
for the autopsy, which was performed in accordance 
with the institution’s ethics guidelines.
AUTOPSY FINDINGS
At autopsy, the patient was found to have a 
pancreatic mass (1.9 × 1.8) cm (Figure 2) composed of 
sheets of large lymphoma cells. Similar lymphoma cells 
were also seen within vessels (mainly in small vessels, 
capillaries, and venules) in nearly all the examined 
organs (lungs, liver, kidneys, thyroid, pancreas, ovary, 
uterus, bladder, leptomeninges, brain parenchyma, 
brain stem, and spinal cord dura). Larger organizing 
occlusive thromboemboli with predominant neoplastic 
cell components were identified in the left pulmonary 
artery (15.5 cm), and the segmental right upper and 
lower lobe pulmonary arteries, the right atrial thrombus 
(2.8 cm), and the intrahepatic right portal vein (6 cm). 
The pancreas showed a mass-forming 2 cm lesion 
composed of dysplastic lymphocytes, and the pancreas 
had multiple nodules of extravasated dysplastic cells 
(1.5 cm each).
Pink-tan, friable, large (up to 2 cm) paraesophageal 
and perihepatic lymph nodes were identified at autopsy 
and sampled. Histopathologic examination showed 
hemorrhagic lymph nodes with complete effacement 
by large dysplastic lymphocytes and necrosis.
The spleen weighted 350 gm and had an 
opaque purple-gray capsule. The parenchyma was 
dark-red-purple, congested, and grossly without distinct 
masses or nodules. On histopathologic evaluation, 
the white pulp was effaced with diffuse sinusoidal 
infiltration by large pleomorphic lymphocytes.
Grossly, the liver (1520 gm) parenchyma had a 
yellow-brown nutmeg appearance and was diffusely 
infiltrated by small firm white nodules. The central liver 
was soft and brown, corresponding to histopathologic 
necrosis. There was a 6 cm occlusive thrombus in the 
right intrahepatic portal vein and a 2 cm occlusive 
thrombus in a branch of the left intrahepatic portal 
vein with a surrounding area (3.0 × 1.5 × 1.0 cm) 
that was firm, ill-defined, white, and infiltrative, 
which corresponded to extravasated neoplastic cells 
on histopathology. There were no signs of infection, 
grossly or histopathologically.
The portal vein thrombosis was related to 
neoplastic involvement, as the thrombus was 
predominantly composed of neoplastic lymphocytes. 
Figure 2. Post-mortem gross image of the pancreatic 
mass (arrow).
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The neoplastic lymphoid cells were larger in size with 
large pleomorphic nuclei and irregular prominent 
nucleoli. Some anaplastic cells were seen with larger 
more atypical features. The tumor burdens were largely 
within the vasculature. CD20, PAX5, CD5, CD10, 
MUM1, CD3, and Ki-67 immunohistochemistry stains 
were obtained on the pancreatic mass (Figure 3) and 
the lung tissue (Figure 4). The malignant cells were 
positive for CD20 (strong), MUM1 (weak), Pax-5 (weak) 
and CD5, and were negative for CD3 and CD10. 
Ki-67 showed a high proliferative index (>90%). 
The Epstein-Barr encoding region in situ hybridization 
was negative.
DISCUSSION
We report the findings on a 71-year-old woman 
with no significant past medical history who presented 
with 3-month history of fatigue, anorexia, and 
abdominal pain, who was found to be anemic, mildly 
thrombocytopenic, with abnormal liver function 
tests, and a ~2 cm pancreatic nodule diagnosed as 
DLBCL. The patient followed an inexplicably fulminant 
clinical course and succumbed less than 2 weeks 
after admission. The discrete pancreatic mass initially 
diagnosed as DLBCL at postmortem examination 
was proven to be a manifestation of widespread 
IVLBCL, which was an astounding discovery not 
previously described in the literature. A recent 
report has described a case of nodular goiter of the 
thyroid ultimately diagnosed as IVLBCL.1 However, 
the lymphoma cells in the thyroid were harbored 
exclusively intravascularly. In our case, the radiographic 
findings of the pancreatic mass mostly resembled 
pancreatic carcinoma or neuroendocrine tumor, and 
the initial needle core biopsy proved inconclusive 
after extensive immunohistochemistry targeting those 
entities. However, evidence of lymphomatous origin 
Figure 3. Photomicrography of pancreatic mass section is seen in A (H&E 10x). CD5, CD20 and Ki67(20x) 
immunohistochemistry stains in B, C and D, respectively, show intravascular infiltration of the lymphoma cells, 
which were positive for CD20 and CD5 with a high Ki67 proliferation index.
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was detected at cytologic examination of concomitant 
fine needle aspiration; morphologic examination 
and immunostaining performed on the cytology cell 
block were diagnostic of DLBCL, which could not be 
further characterized due to tissue paucity. Subsequent 
negative clinical staging suggesting that the lymphoma 
was restricted to the approximately 2 cm pancreatic 
nodule resulted in a clinical conundrum, as the patient’s 
general condition rapidly deteriorated despite robust 
antibiotic therapy, which drew increasing skepticism 
among infectious disease team members regarding 
the alleged infectious etiology. An incomprehensible 
tumor lysis syndrome was contemplated but the 
patient’s dismal conditions cautioned against systemic 
chemotherapy while at the ICU. Only the postmortem 
examination unveiled a widely disseminated IVLBCL, 
which ultimately accounted for the patient’s demise. 
Retrospectively, we could not find evidence of an 
Figure 4. Photomicrography of representative lung section is seen in A (H&E 10x). CD20, CD5 and Ki67 
immunohistochemistry stains in B, C and D, respectively, show intravascular infiltration by lymphoma cells positive 
for CD20 and CD5, with a high Ki67 proliferation index.
intravascular component on the cytology specimen, but 
it was clearly present on sections obtained at necropsy.
IVLBCL was first described in 1958 by Pfleger 
and Tappeiner as a very rare form of DLBCL that 
proliferates within small blood vessels.2 According 
to the 2008 WHO classification, this has been 
categorized as a rare type of non-Hodgkin lymphoma. 
The main characteristic of IVLBCL is diffuse, occlusive, 
intravascular, lymphomatous proliferation affecting 
the capillaries, small arteries, and veins.3,4 IVLBCL 
can involve any organ of the body, but typically the 
lymph nodes are spared. In 2014, Fonkem et al.5 
retrospectively analyzed 740 cases of intravascular 
lymphoma between 1959 and 2011, among which 
651 were IVLBCL. This retrospective research found 
that the central nervous system, bone marrow 
spleen, skin, and lung involvement was present in 
60%, 11%, 11%, 8% and 7% of cases, respectively.
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The pathogenesis of IVLBCL is unclear, and an 
explanation accounting for its affinity to vascular 
beds remains elusive. Conceivably, adhesion molecule 
dysfunction would partly explain why lymphoma 
cells remain stationary within the lumen of vessels.6 
Histologically, lymphoma cells are large and mitotically 
active with prominent nucleoli. Histopathology remains 
the gold standard for diagnosis, showing the classic 
appearance of large malignant lymphocytes filling the 
small vascular lumen. Immunohistochemically, the cells 
express B-cell markers with an aberrant expression of CD5 
and, less likely, CD10, by a portion of cases. The clinical 
manifestations of IVLBCL are non-specific; fever, weight 
loss, progressive neurologic deficits, skin findings, and 
sweating are the most common presentations.7 Increased 
serum LDH and C-reactive protein are found in most 
cases, accompanied by anemia and decreased platelets 
and a white blood cell count.
The pancreatic lesion described here with 
extravascular extension into the pancreatic parenchyma 
(as shown in Figure 3) is uncanny. We believe this 
represents a feature not previously described in other cases 
of IVLBCL. Apart from that, our case is indistinguishable 
from other IVLBCL, albeit we found other unusual 
features such as large vessel involvement, including 
portal vein and pulmonary arteries, and the infiltration 
of para-esophageal and para-aortic lymph nodes. It is to 
be noted that CD5+ DLBCL often presents with low-level 
blood involvement, as well as visceral involvement of the 
liver, spleen, and bone marrow, which begs the question 
of a possible relationship reflecting the spectrum of a 
disease with common lymphomatous origin.
While the diagnosis of IVLBCL is undisputable 
in light of the autopsy findings of extensive systemic 
small- and medium-sized vessel engorgement with 
large CD5+ lymphoma cells, the initial presentation of 
a discrete head of the pancreas mass that was biopsy 
proven CD5+ DLBCL, while the patient was still alive, 
represents a new clinical feature of this poorly understood 
lymphoma. In retrospect, this partly explains why the 
patient underwent tumor lysis after initial steroid therapy, 
which was out of proportion to the limited tumor burden 
she was thought to have at the time of diagnosis. This was 
attributed to concomitant sepsis, which the Infectious 
disease service deemed unlikely, although no better 
explanation could be hypothesized at the time.
Therefore, it is important to consider this diagnosis 
in the appropriate settings because patients may 
achieve durable remission with early diagnosis and 
rituximab-containing chemotherapy, which has improved 
the outcome of IVLBCL therapy.8-10
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